Evidence map›Paper›PMID 24002703›Full record

ArticleMolecular and cellular biochemistry2013

Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling.

Xianghong Wu, Wen Huang, Gang Luo, Laval Andy Alain

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Protein⁻Protein Interactions with Connexin 43: Regulation and Function.International journal of molecular sciences · 2018
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xianghong WuDepartment of Cardiology, First Affiliated Hospital, Guangxi Medical University, Nanning, People's Republic of China.
Wen Huang
Gang Luo
Laval Andy Alain
Guangxi Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Connexin 43 (Cx43) is a major structural protein found in the gap junctions of the ventricular myocardium and a major determinant of its electrical properties. The effects of matrix metalloproteinases (MMPs), the mitogen-activated protein kinase (MAPK) signaling pathway, transcription factor NF-kB, and activator protein-1 (AP-1)/c-Jun on the regulation of Cx43 gene expression in H9c2 cardiomyocytes were assessed. The MAPK signaling pathway (MEK/ERK1/2 and PI3K) and transcription factors NF-kB and AP-1/c-Jun were inhibited, then Cx43 expression was assessed using Western blot analysis, and MMP-9 activity was assessed using gelatin zymography. Hypoxia decreased the Cx43 protein level by approximately 30-50 %. Doxycycline (10 μg/mL), an inhibitor of MMP, markedly attenuated the hypoxia-induced downregulation of Cx43 protein expression at 6 h. The hypoxia-induced decrease in Cx43 protein expression was significantly reversed by U0126 (10 μM), a MEK/ERK1/2 inhibitor, at 6 and 12 h; LY294002 (30 μM), a PI3K inhibitor, downregulated Cx43 expression. Hypoxia-induced MMP-9 activation was inhibited by treatment with LY294002, U0126, and, most especially, U0126. JSH-23 (30 μM), an NF-kB inhibitor, and SP600125 (10 μM), an AP-1/c-Jun inhibitor, attenuated the loss of Cx43. These results suggest that MAPK signaling and the activities NF-kB and MMPs play an important roles in the regulation of Cx43 expression.

Indexed as

AnimalsAnthracenesButadienesCell HypoxiaCells, CulturedCell SurvivalChromonesConnexin 43Down-RegulationDoxycyclineEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGene Expression RegulationJNK Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemMatrix Metalloproteinase 92-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamineAnthracenesButadienesChromonesConnexin 43DoxycyclineEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesGja1 protein, ratJNK Mitogen-Activated Protein KinasesMatrix Metalloproteinase 9Mmp9 protein, ratMorpholinesNF-kappa BNitrilesPhenylenediaminesPhosphoinositide-3 Kinase InhibitorspyrazolanthroneTranscription Factor AP-1U 0126

Identifiers

PMID24002703
PMCPMC3825321
OpenAlexW2013792255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.